Skip to main content

Table 1 Characteristics of pregnant women with MNT-GDM, iGDM, or normal glucose tolerance

From: N-terminal-pro-brain natriuretic peptide is decreased in insulin dependent gestational diabetes mellitus: a prospective cohort trial

 

MNT-GDM

iGDM

normal

n

45

90

88

Age (years)

29 ± 5 P = 0.034*

32 ± 5 p = 0.046

32 ± 6

Gestational week

28 ± 5

28 ± 5

27 ± 4

Fasting glucose (mg/dl)

84 ± 13

91 ± 14 p < 0.001* p = 0.012

75 ± 10

oGTT 60 Min (mg/dl)

187 ± 28 p < 0.001*

188 ± 33 p < 0.001*

138 ± 33

oGTT 120 Min (mg/dl)

137 ± 25 p < 0.001*

143 ± 26 p < 0.001*

104 ± 22

HbA1c (%)

4.9 ± 0.3

5.1 ± 0.4 P = 0.02*

4.8 ± 0.5

HbA1c (mmol/mol)

30 ± 3

32 ± 4 P = 0.02*

29 ± 5

NT-proBNP (pg/ml)

46 ± 40

35 ± 25 P = 0.012*

53 ± 43

  1. Data are means ± SD. GDM: gestational diabetes mellitus; MNT: medical nutrition therapy; iGDM: insulin dependent GDM; oGTT: oral glucose tolerance test; NT-proBNP: N-terminal pro brain natriuretic peptide; HbA1c: glycosylated hemoglobin; * p-value versus normal pregnancies; p-value versus MNT-GDM